Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.
With AI advancements upending the role of senior executives, the question is what the C-suite transformation should look like ...
Chronic degenerative joint diseases, such as osteoarthritis and rheumatoid arthritis, are progressive conditions largely defined by the degradation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback